Orchid Pharma Limited, headquartered in Chennai, India, is a prominent pharmaceutical company specializing in the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs), Finished Dosage Forms, and nutraceuticals. Established as a 100% Export Oriented Unit in 1992, Orchid Pharma operates state-of-the-art facilities compliant with international standards like US FDA and UK MHRA. With a manufacturing presence in Alathur and Aurangabad, and R&D centers in Chennai, Orchid Pharma exports to over 40 countries, focusing on antibiotics and anti-infective formulations.
The company has a strong history of strategic collaborations, including partnerships with Merck & Co and Par Pharmaceuticals, and has expanded its global footprint through subsidiaries in the USA, Japan, and South Africa. Orchid Pharma became a subsidiary of Dhanuka Laboratories Limited in 2020 following a successful resolution plan. The company's extensive portfolio includes various classes of antibiotics, and it continues to innovate in drug discovery and development.
